Companies Funding Layoffs Technical Review 
Startup Professionals Musings
AUGUST 7, 2020
In a larger public company, it’s all about making your quarterly numbers, versus investing in strategic growth alternatives that may not pay off until several quarters later. In my experience, even in startups, longer-term strategy often gets pushed off the agenda due to current challenges. Cote, former Chairman and CEO of Honeywell.
TechCrunch LA
APRIL 24, 2020
The company, which employed about 160 people, laid off 57 workers, according to documents filed with the California Employment Development Department. However, he did confirm to TechCrunch that he had to reduce staff due to the COVID-19 pandemic. The company’s No. The company’s No.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
MAY 23, 2012
Heavily backed, concentrating solar photovoltaic technology developer Amonix , which is based in Seal Beach, is set to lay off 76 workers across its offices in California, according to regulatory filings with the state. The company also had received a $90M Department of Energy loan guarantee. round in 2010. READ MORE>>.
socalTECH
FEBRUARY 17, 2017
He eventually founded and sold consumer health firm ViSalus to a public company and is now back making investments, in technology companies, as a venture capitalist here at Los Angeles-based HashtagOne (www.hashtagone.com). After we sold it to that public company, I founded HashtagOne. It's all about leverage.
Xconomy
OCTOBER 7, 2016
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. The funding could be as much as $100 million, and the first grants will be announced in 2017. —The U.S. PRICE FIGHTS.
Xconomy
JULY 1, 2016
There was plenty more biomedical news this week, from a downsized IPO to downsizing companies, while ugly sexual harassment details emerged in Seattle. To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence.
Xconomy
JULY 15, 2016
There were other goodbyes: Peter DiLaura said so long to Second Genome, the microbiome company he led for six years. —The federal group that runs Medicare and Medicaid banned Theranos CEO Elizabeth Holmes from running a lab for two years, throwing into question the viability of the company. —In other Merck news, U.K.-based
Expert insights. Personalized for you.
124 
Let's personalize your content